Peter Koetsier’s Post

At Biortica Agrimed, we're confronting the stark reality of the Australian medical cannabis market head-on. Despite the presence of numerous licensed producers, Australia remains heavily reliant on imports, a trend exacerbated by the recent surge in flower imports. In 2022 alone, Australia imported a staggering 24,887 kg of medical cannabis while exporting a mere 1510 kg, as reported by the TGA (Therapeutic Goods Administration). We firmly assert that cultivating high-quality medicinal cannabis isn't just an option; it's a necessity for Australian patients and the local industry. Quality isn't just a preference; it's the cornerstone of optimal patient outcomes and the bedrock of a robust Australian cannabis sector. Join us as we lead the charge towards excellence and reshape the future of Australian medical cannabis. 🌱 #AustralianCannabis #QualityFirst #PatientCare

It is important for the Australian cannabis industry to look at itself in the mirror and ensure that we are delivering high quality medicinal cannabis that can compete globally if we want to stay in the game. This is an important point that sometimes is lost on people when there is criticism of local cultivation. But what we also have to remember is that there are a lot of Australian cultivators doing great things. If we work together, share knowledge and raise the bar for Australian grown product then 'the rising tide will float all boats'. Stopping imports is not the answer...but neither is allowing the current lack of accountability and regulation around import! Biortica is committed to leading the charge on producing quality medicinal cannabis and we know we do not stand alone. Here is to all the Australian cannabis cultivators growing quality product...keep up the good work.

At Biortica, our mission is clear: to set the highest standards and prioritise the well-being of patients above all else. In a recent discussion with MMJdaily.com, CEO Tom Varga emphasised the importance of patient-centred care, echoing sentiments from Dr. Michael Clements of The Royal Australian College of General Practitioners (RACGP): "the need to put patients first and prescribe the best product for their indications is paramount." We believe in prescribing the best product for each patient's unique needs, ensuring they receive the care they deserve. Teresa Nicoletti from the Australian Medicinal Cannabis Association shared her insight—"The number of patients genuinely benefiting from medicinal cannabis cannot be disregarded"—this further underscores our commitment to improving lives through compassionate care.   Discover how Biortica is helping to raise the bar for Australian medicinal cannabis in this recent MMJ Daily article. 🔗 Read the full article here: https://lnkd.in/gwzSQDZE #IndustryInnovation #MedicinalCannabis #PatientCare #AustralianCannabis #MMJDaily #BiorticaAgrimed

As more countries legalize cannabis for medical and recreational use, the global market for cannabis is expected to reach new heights. Get ahead of the curve by investing in this industry now. #UnitedStatesCannabis, #CanadaCannabis, #ThailandCannabis, #GermanyCannabis, #UruguayCannabis, #SouthAfricaCannabis, #AustraliaCannabis #CannabisMarket #MarijuanaStocks #CannabisInvestment #CannabisBusiness #GreenRushInvesting

Quoting the below Biortica Agrimed post "In 2022 alone, Australia imported a staggering 24,887 kg of medical cannabis while exporting a mere 1510 kg" It's important to support Australian manufacture so I'd love to see this number turned on its head in 5+ years, and that's not taking into account the industry/market growth from 2023 to 2024 and beyond! Is there a figure for how much medicinal cannabis is currently used in Australia? Could this figure be doubled or trebled in the next 5 years as more and more people become aware of the products benefits. Certainly interesting times ahead.

🌿 January 2024 brings key developments in the cannabis industry. CBD isolate prices, US rescheduling, Medical Cannabis evolution, semi-synthetic cannabinoids and more insights in our monthly Newsletter. Stay updated with CanXChange. Subscribe here https://lnkd.in/dg-5vcZY. #CanXChange #CannabisExchange #CannabisIndustry#IndustrialCannabis #CannabisMarket2023 #GlobalTrends #CBDTrends #HempSeedDemand #InvestmentOpportunities Sigfried Legeay Alex Arkentis Joe Seaman

As we enter a new year, what should the UK's priorities be to drive forward the #medicalcannabis industry in 2024? In our latest report, we suggest six recommendations: 1️⃣ Improve NHS funding pathway 2️⃣ Allow GPs to initiate prescriptions 3️⃣ Adjust Proceeds of Crime Act 2002 4️⃣ Revisit NICE guidance 5️⃣ Allow harvesting of hemp flower 6️⃣ Establish Office of Medicinal Cannabis 📑 Download UK Medical Cannabis: Five Years On, Maple Tree's overview, discussion, and recommendations to learn more: https://lnkd.in/gENKMuh7

Did you know that while medical cannabis is legal in Denmark, its market presence is still relatively small compared to its European neighbors? Strict regulations, high prices, and unique medical programs shape Denmark's unique cannabis story. From authorized medicines like Sativex and Epidiolex to the country's four-year medicinal cannabis pilot program (extended until 2025), Denmark offers a complex web of options for patients in need. However, despite these available avenues, many patients have turned to the illegal market due to the barriers in pricing and prescription reluctance. Denmark's EU membership allows cross-border prescriptions, but a medical pass is required and there's a 30-day supply limit. We've outlined the entire landscape, including the prominence of industrial hemp cultivation since 1998 and how it contrasts with medicinal cannabis cultivation. 🌾 👉 Dive into the full post for a comprehensive look at Denmark's evolving relationship with cannabis, from regulations and availability to the challenges faced in the medical cannabis initiative. https://hubs.ly/Q027W0_q0 #GQCan #Cannabis #MedicalCannabis #Denmark #Healthcare #Regulations

Medicinal cannabis may help with erectile dysfunction in men 🖱 Click here to read more about the benefits of medicinal cannabis for men. - https://bit.ly/3rpD0Bn #introcann #cannabissouthafrica #cannabissa #cannabiscommunity #cannabisismedicine #cannabisfordoctors #menshealthawareness 

Emerging markets such as #medicalcannabis present a currently untapped opportunity for the UK economy which continues to face uncertainty. In our latest publication, we explore the untapped economic impact of a vibrant medical cannabis market. The UK #CBD market alone is estimated to be worth around £690 million and is predicted to be worth £1 billion by 2025. The UK economy is currently at risk of missing out on these commercial benefits and the potential tax revenue which could be generated. Since legalising medicinal cannabis in 2018, the US state of Oklahoma is already generating $30m per annum from the industry. When the same rate is applied to the UK population this comes out at a potential $495m. 📑 Download UK Medical Cannabis: Five Years On, Maple Tree's overview, discussion, and recommendations to learn more: https://lnkd.in/gENKMuh7